Revenue Cycle Management M&A Advisory

Growth in reimbursement challenges, resource requirements and outsourcing are increasing providers’ demand for sophisticated Revenue Cycle Management (RCM) solutions. Kroll has successfully advised privately owned, sponsor-backed businesses and other middle-market companies on their RCM solutions. Our team provides consistent, independent and objective M&A advisory support, resulting in strong outcomes for shareholders and management.

Supporting Client Objectives:
 
Kroll’s global transaction team consists of senior bankers with deep expertise in the RCM sector. The transaction team strives to maintain an active dialogue with key financial investors/buyers and are thought leaders in the industry. Clients rely on Kroll’s extensive RCM experience. Our differentiators include:

• Trusted transaction experience with RCM businesses, including several recent closings in the sector
• Valuable sales process for buyers in the strategic and financial field
• Collaborative relationship between Kroll bankers and management team to develop detailed financial projections and company positioning that delivers a long-lasting message to the marketplace to achieve a better outcome for shareholders
• Active dialogue with a variety of buyers from the strategic, private equity and family office regions active in the healthcare services sector
• Dedicated Financial Sponsors Group that support mutually long-term relationships with leading private equity firms
• Recent transactions in the RCM sector that provides real-time market feedback on RCM industry trends, buyers activity, valuation metrics, etc.

Kroll is a Leader in Corporate Finance and M&A Advisory

Kroll is the #5 ranked U.S middle-market advisor over the past 10 years, with over 600 firm wide M&A transactions completed in that time.¹

Why Kroll

• Senior-level attention and involvement at each stage of the transaction process
• One of the broadest financial sponsor and family office coverage effort in the middle market
• Breadth of in-house corporate finance and financial advisory services, which significantly enhance our Industrial M&A processes and outcomes for our clients
• Healthcare is one of five core industry verticals for Kroll’s Corporate Finance Practice
• We are the finical advisor and exclusive placement agent for national and global healthcare technology companies that provide services to healthcare providers, healthcare clients, and others

Source: 
¹ Refinitiv Data (U.S. deals $10M < $170M, including deals without a disclosed value). Full years 2012 through 2021.